AEON Biopharma Inc.

0.75
0.02 (2.74%)
At close: Mar 18, 2025, 3:59 PM
0.74
-1.05%
After-hours: Mar 18, 2025, 08:00 PM EDT

AEON Biopharma Income Statement

Year FY22 FY21 FY20 FY19
Revenue n/a n/a 2.52M 3.36M
Cost of Revenue n/a n/a n/a 1K
Gross Profit n/a n/a 2.52M 3.36M
Operating Income -48.43M -65.85M -16.39M -53.97M
Interest Income n/a n/a n/a 720K
Pretax Income -52.56M -55.64M -32.91M 145.67M
Net Income -52.56M -55.64M -32.91M 172.92M
Selling & General & Admin 13.68M 11.15M 11.59M 46.04M
Research & Development 34.75M 25.73M 7.32M 4.81M
Other Expenses n/a 10.21M -5.61M -10.75M
Operating Expenses 48.43M 36.88M 18.91M 51.73M
Interest Expense n/a n/a 15K 7.47M
Selling & Marketing Expenses n/a n/a n/a n/a
Cost & Expenses 48.43M 36.88M 18.91M 51.73M
Income Tax -160.49K 28.97M 15K -14.64M
Shares Outstanding (Basic) n/a 22M 14.8M 14.8M
Shares Outstanding (Diluted) n/a 22M 14.8M 14.8M
EPS (Basic) n/a -2.53 -2.22 11.69
EPS (Diluted) n/a -2.53 -2.22 11.69
EBITDA -48.36M -7.91M -22.14M -50.41M
Depreciation & Amortization 68K 3K -5.75M 1.26M